This article was originally published in The Tan Sheet
Nancy Snyderman, MD, will assume newly created role of VP-medical affairs Jan. 2. Snyderman, who will report to Corporate VP-Public Affairs Bill Nielsen, will advise J&J "on the introduction of new technologies across" the firm's "broadly based lines of consumer, pharmaceutical, medical device and diagnostics businesses." Snyderman has been working as a medical correspondent at ABC News and runs a head and neck surgery practice...
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.